
A Newcastle review highlights missing diet data in GLP-1 research, with practical implications for nutrition, strength and active travel.

On October 20, 2026, University of Newcastle professor Clare Collins reported in The Conversation that research on GLP-1 medicines had paid little attention to what users actually ate. Her team reviewed 41 studies involving about 50,000 people, but only two recorded what participants ate in response to treatment. For an active adult who values travel and physical independence, that gap matters.
The Age’s reporting notes that these medicines can support weight loss and improve blood-glucose control. Alongside those benefits sits a practical question: when appetite falls substantially, is the food someone still eats providing enough protein and other nutrients?
For anyone thinking about healthy aging during GLP-1 treatment, the relevant outcome extends beyond a lighter body. It includes retaining the strength for a walking holiday and the energy to enjoy an active day.
The concern begins with a straightforward relationship. Eating less can reduce overall energy intake, but it can also reduce opportunities to obtain protein and essential nutrients. Experts quoted by The Age warn that substantially reduced intake may make nutritional adequacy harder to maintain.
Protein matters here because the concern is maintaining muscle during weight loss. Collins also highlights nutrients involved in functions such as wound healing and energy production. The practical issue is therefore the nutritional content of the smaller amount of food being eaten.
Collins’s account of a separate review provides a concrete example of appetite-related change. Across four controlled test-meal studies, average lunch energy intake was 1,132 kilojoules lower after participants reached stable medication doses than before treatment. That finding describes intake at a controlled meal rather than a complete picture of someone’s everyday diet.
For a person eating substantially less, the useful question becomes what remains on the plate. A smaller meal may still contain varied protein foods and other nutrient-rich choices. The amount eaten and its nutritional quality are related questions, but they are not interchangeable.
Dietitian Lauren Franklin told The Age that scientific evidence directly linking GLP-1 use with malnutrition remains limited. She described a theoretical risk that warrants attention and raised the possibility that deficiencies could go unrecognized if they are not routinely tested for.
A clinical summary of a separate review of randomized trials adds context. None of the included trials directly tested dietary advice during GLP-1 treatment. The review reported that fat-free mass decreased in proportion to weight loss and that no clinically relevant nutrient deficiencies were reported in those trials.
Taken together, these findings do not establish how common malnutrition is among GLP-1 users or demonstrate that the medicines directly damage muscle. They also provide neither a universal protein target nor a prevention plan proven to eliminate risk. The practical travel implications are therefore about sensible nutrition planning rather than a demonstrated improvement in recovery or sporting performance.
Collins’s description of protein as helping to “feed and protect” muscles gives the concern a useful focus. In The Age’s reporting, her point is that reduced food intake can leave less room for the nutrients needed to support the body’s everyday functions.
That framing shifts attention from weight alone to capability. For someone whose priorities include hiking or skiing, a nutrition conversation should account for strength and energy as well as weight change. The aim is to make the treatment discussion more complete.
The Age also reports that fatigue, nausea, diarrhoea and constipation may overlap with signs of nutritional problems. Appetite changes and persistent symptoms are therefore useful information for the prescribing clinician rather than something to interpret through guesswork.
The clearest practical response is to make changes in eating visible. That gives the prescribing clinician or dietitian something concrete to work with and keeps the discussion focused on an individual’s circumstances.
Collins suggests considering a food diary when appetite or digestive side effects make intake erratic. She also recommends asking a doctor about a dietitian referral. These are manageable ways to bring nutrition into the treatment conversation without creating a demanding tracking routine.
The record serves a practical purpose: showing what is actually being eaten. It can give a more useful starting point than a general impression that meals have become smaller. The aim is a clearer conversation about intake, not a score to optimize.
That makes the food record a sensible first action before adding several new dietary rules. It keeps attention on the problem being experienced rather than on a generic plan designed for someone else. Personal nutrition decisions can then sit with a qualified professional who understands the person’s health and treatment.
The experts quoted by The Age suggest varied protein foods and nutrient-rich snacks. They also include fibre and hydration in the discussion. These are areas for individualized attention when appetite has changed substantially.
For severely reduced appetite, the reporting also mentions meal-replacement products as an option to discuss with a GP or dietitian. Their suitability is a personal nutrition decision rather than a default response to eating less. The useful sequence is to establish what intake looks like and then consider which support fits.
This approach keeps the task realistic. Someone does not need to turn every meal into a nutrition project to raise a meaningful concern. A clear account of reduced appetite gives a professional a starting point for tailored advice.
A walking holiday or ski trip makes the issue more concrete: is there a workable eating pattern when appetite is low? For travel, the practical application of Collins’s advice is to discuss an erratic pattern before carrying it into an active itinerary.
That conversation can include the activities planned and the symptoms already being experienced. Mentioning persistent nausea or weakness alongside the food record gives the clinician relevant context. It connects the nutrition discussion to what the person wants to remain able to do.
Travel recovery also deserves a place in that conversation. If weakness or persistent gastrointestinal symptoms are already present, they are relevant to plans for repeated active days. The research-supported response is clinical review of those concerns rather than assuming they are simply part of treatment.
For sustained energy during hiking or skiing, the useful question is how to maintain adequate intake within a reduced appetite. The Age’s suggestions around nutrient-rich foods and hydration provide topics to discuss. The personal plan should account for the demands of the trip as well as everyday eating.
Nutrition is one part of preserving physical capability during weight loss. In a separate University of Auckland discussion, experts argued that exercise should be a core part of care while weight is falling. They particularly emphasized progressive resistance training to help preserve muscle, strength and physical capacity.
That places strength-preserving activity alongside the food conversation. It also makes maintaining muscle and performance during weight loss a useful frame for assessing priorities beyond body weight. The exercise and nutrition plan should reflect the individual’s health and circumstances.
For an active adult, the discussion can remain grounded in ordinary ambitions: continuing to hike or enjoying a ski holiday with confidence. Those goals help explain why strength matters during weight loss. They give the clinical conversation a practical destination without requiring an elaborate performance regimen.
The central action remains simple: make changes in appetite and intake visible. From there, qualified care can address nutrition and activity together. That is a more useful response to this research than either dismissing the concern or treating every smaller meal as evidence of harm.
Keep capability central during GLP-1 weight loss by bringing appetite changes and a simple food record into clinician-guided nutrition planning, with strength-preserving activity remaining part of the conversation.
Stay connected for research and practical guidance on longevity, strength, recovery, energy and active living. New ideas to help you stay capable, curious and ready for more.



Explore practical guidance on strength, recovery, energy, travel and longevity for a life that stays active.
explore the Blog